Electrospraying as a Technique for the Controlled Synthesis of Biocompatible PLGA@Ag2S and PLGA@Ag2S@SPION Nanocarriers with Drug Release Capability
Metadata
Show full item recordAuthor
Alvear Jiménez, Alexis; García Pinel, Beatriz; Prados Salazar, José Carlos; Melguizo Alonso, ConsolaciónEditorial
MDPI
Materia
Electrospraying Ag2S nanoparticles SPIONs Hybrid system Chemotherapeutic drug Drug release
Date
2022-01-17Referencia bibliográfica
Alvear-Jiménez, A... [et al.]. Electrospraying as a Technique for the Controlled Synthesis of Biocompatible PLGA@Ag2S and PLGA@Ag2S@SPION Nanocarriers with Drug Release Capability. Pharmaceutics 2022, 14, 214. [https://doi.org/10.3390/pharmaceutics14010214]
Sponsorship
Comunidad de Madrid 2018-T1/IND-10736 IND2020/BIO-17523; Universidad Complutense de Madrid CT63/19-CT64/19; Junta de Andalucia P18-HO-3882 P20_00540 A-CTS666-UGR20-FEDER; Instituto de Salud Carlos III European Commission PI19/01478-FEDER DTS20/00109; Spanish government (MICIU) through the Ramon y Cajal research program RyC2019-028414-I; Comunidad de Madrid 2017T1/BIO-4992Abstract
Ag2S nanoparticles are near-infrared (NIR) probes providing emission in a specific spectral
range (~1200 nm), and superparamagnetic iron oxide nanoparticles (SPION) are colloidal systems able
to respond to an external magnetic field. A disadvantage of Ag2S NPs is the attenuated luminescent
properties are reduced in aqueous media and human fluids. Concerning SPION, the main drawback is
the generation of undesirable clusters that reduce particle stability. Here, we fabricate biocompatible
hybrid nanosystems combining Ag2S NPs and SPION by the electrospraying technique for drug
delivery purposes. These nanostructures are composed of poly(lactic-co-glycolic acid) (PLGA) as
the polymeric matrix in connection with both Ag2S NPs and SPIONs. Initially, we fabricate a hybrid
colloidal nanosystem composed of Ag2S NPs in connection with PLGA (PLGA@Ag2S) by three
different routes, showing good photoluminescent (PL) properties with relatively high average decay
times. Then, we incorporate SPIONs, obtaining a PLGA polymeric matrix containing both Ag2S
NPs and SPION (PLGA@Ag2S@SPION). Interestingly, in this hybrid system, the location of Ag2S
NPs and SPIONs depends on the synthesis route performed during electrospraying. After a detailed
characterization, we demonstrate the encapsulation and release capabilities, obtaining the kinetic
release using a model chemotherapeutic drug (maslinic acid). Finally, we perform in vitro cytotoxicity
assays using drug-loaded hybrid systems against several tumor cell lines.